Recent Publications
TET2 coactivates gene expression through demethylation of enhancers.
Wang L,… Smith ER … Shilatifard A …
Sci Adv. 2018 Nov 7;4(11):eaau6986. doi: 10.1126/sciadv.aau6986. eCollection 2018 Nov.
Wang X,… Wang X …
Adv Mater. 2018 Oct 29:e1805615. doi: 10.1002/adma.201805615. [Epub ahead of print]
Aubert G, Ajroud-Driss S, Knight BP, Shah SJ, McNally EM.
Circulation. 2018 Sep 18;138(12):1267-1271. doi: 10.1161/CIRCULATIONAHA.118.035577. No abstract available.
Targeting Processive Transcription Elongation via SEC Disruption for MYC-Induced Cancer Therapy.
Liang K,… Smith ER … Hashizume R … Shilatifard A …
Cell. 2018 Oct 18;175(3):766-779.e17. doi: 10.1016/j.cell.2018.09.027.
CD95/Fas ligand mRNA is toxic to cells.
Putzbach W, Haluck-Kangas A, Gao QQ, Sarshad AA, Bartom ET, Stults A, Qadir AS, Hafner M, Peter ME.
Elife. 2018 Oct 16;7. pii: e38621. doi: 10.7554/eLife.38621.
Inheritance of CENP-A Nucleosomes during DNA Replication Requires HJURP.
Zasadzińska E, Huang J, Bailey AO, Guo LY, Lee NS, Srivastava S, Wong KA, French BT, Black BE, Foltz DR.
Dev Cell. 2018 Nov 5;47(3):348-362.e7. doi: 10.1016/j.devcel.2018.09.003. Epub 2018 Oct 4.
Trinucleotide Repeat Expansion Diseases, RNAi, and Cancer.
Murmann AE, Yu J, Opal P, Peter ME.
Trends Cancer. 2018 Oct;4(10):684-700. doi: 10.1016/j.trecan.2018.08.004. Epub 2018 Sep 26. Review.
Dusp6 is a genetic modifier of growth through enhanced ERK activity.
Vo AH, Swaggart KA, Woo A, Gao QQ, Demonbreun AR, Fallon KS, Quattrocelli M, Hadhazy M, Page PGT, Chen Z, Eskin A, …
Hum Mol Genet. 2018 Oct 5. doi: 10.1093/hmg/ddy349. [Epub ahead of print]
A C6orf10/LOC101929163 locus is associated with age of onset in C9orf72 carriers.
Zhang M,… Zhang M …
Brain. 2018 Oct 1;141(10):2895-2907. doi: 10.1093/brain/awy238.
Are MicroRNAs Key to Developing Biomarkers for Cutaneous T-Cell Lymphoma?
Martinez-Escala ME, Choi J.
J Invest Dermatol. 2018 Sep;138(9):1906-1908. doi: 10.1016/j.jid.2018.04.012.
Berberine promotes glucose uptake and inhibits gluconeogenesis by inhibiting deacetylase SIRT3.
Zhang B, Pan Y, Xu L, Tang D, Dorfman RG, Zhou Q, Yin Y, Li Y, Zhou L, Zhao S, Zou X, Wang L, Zhang M.
Endocrine. 2018 Aug 16. doi: 10.1007/s12020-018-1689-y. [Epub ahead of print]
Meng J, Hussain SA, Mohr DC, Czerwinski M, Zhang M.
J Med Internet Res. 2018 Jul 17;20(7):e10139. doi: 10.2196/10139.
Ma S, Platanias LC.
Expert Opin Pharmacother. 2018 Aug;19(11):1171-1175. doi: 10.1080/14656566.2018.1498844. Epub 2018 Jul 18. No abstract available.
Is Heart Failure Inherited?: Beyond the Cardiomyopathies, Genetics Do Matter.
O'Donnell CJ, Yancy CW, McNally EM.
JAMA Cardiol. 2018 Aug 1;3(8):710-711. doi: 10.1001/jamacardio.2018.1918. No abstract available.
A brief overview of the Swi1 prion-[SWI+].
Goncharoff DK, Du Z, Li L.
FEMS Yeast Res. 2018 Sep 1;18(6). doi: 10.1093/femsyr/foy061.
Morgan MA, Shilatifard A.
Cancer Cell. 2018 Jun 11;33(6):951-953. doi: 10.1016/j.ccell.2018.05.011.
Slfn2 Regulates Type I Interferon Responses by Modulating the NFĸB Pathway.
Fischietti M, Arslan AD, Sassano A, Saleiro D, Majchrzak-Kita B, Ebine K, Munshi HG, Fish EN, Platanias LC.
Mol Cell Biol. 2018 Jun 4. pii: MCB.00053-18. doi: 10.1128/MCB.00053-18. [Epub ahead of print]
Zhou XA, Louissaint A Jr, Wenzel A, Yang J, Martinez-Escala ME, Moy AP, Morgan EA, Paxton CN, Hong B, Andersen EF, …
J Invest Dermatol. 2018 Nov;138(11):2365-2376. doi: 10.1016/j.jid.2018.04.038. Epub 2018 May 30.
Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy.
Wang L,… He X … Smith ER … Ntziachristos P … Hashizume R … Shilatifard A …
Nat Med. 2018 Jun;24(6):758-769. doi: 10.1038/s41591-018-0034-6. Epub 2018 May 21.
Enhancer Logic and Mechanics in Development and Disease.
Rickels R, Shilatifard A.
Trends Cell Biol. 2018 Aug;28(8):608-630. doi: 10.1016/j.tcb.2018.04.003. Epub 2018 May 11. Review.